MONDAY, Nov. 22, 2021 (HealthDay News) — Pfizer Inc. said Monday that its coronavirus vaccine provides long-term protection in youth ages 12-15, according to data from a company clinical trial that included more than 2,200 participants. In a company clinical trial that included more than 2,200 adolescents, getting two dosesContinue Reading
MONDAY, Nov. 22, 2021 (HealthDay News) — Most prescriptions for the medication gabapentin are for unapproved uses — and many patients end up taking it along with drugs that create potentially dangerous interactions. That’s the conclusion of a new study that looked at “off-label” use of gabapentin. In the UnitedContinue Reading
MONDAY, Nov. 22, 2021 (HealthDay News) — Hospitalized COVID-19 patients who take medications that suppress the immune system don’t have a higher risk of severe COVID-19 than those with normal immune systems, a new study finds. Early in the pandemic, it was feared that people taking immunosuppressive drugs were atContinue Reading
FRIDAY, Nov. 19, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Friday granted emergency use of both the Pfizer and Moderna COVID-19 booster shots for all adults, clearing the way to additional vaccine protection for tens of millions of Americans. The announcement came hours before the startContinue Reading
FRIDAY, Nov. 19, 2021 (HealthDay News) — A COVID-19 vaccine booster shot gives cancer patients — especially those with blood cancer — much-needed protection, new research reports. “Our study demonstrates in clear terms how the booster shot can make all the difference for some people with compromised immune systems, suchContinue Reading
FRIDAY, Nov. 16, 2021 (HealthDay News) — Low-dose aspirin neither reduces nor increases the risk of dementia in adults with type 2 diabetes, a new study finds. “This is reassuring that an increase in the risk of dementia is unlikely for the millions of people worldwide who regularly take aspirinContinue Reading
FRIDAY, Nov. 19, 2021 (HealthDay News) — Guidelines for treating movement problems in people in the early stages of Parkinson’s disease have been updated. The new treatment recommendations from the American Academy of Neurology (AAN) focus on dopaminergic medications, which increase dopamine levels or mimic dopamine effects. Parkinson’s is aContinue Reading
THURSDAY, Nov. 18, 2021 (HealthDay News) — Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines. “Aducanumab is not a cure for Alzheimer’s disease,Continue Reading
THURSDAY, Nov. 18, 2021 (HealthDay News) — Lyss Stern lost her sense of smell when she was diagnosed with COVID-19 in March 2020, and it still hasn’t returned. Stern, 47, a New York City author and mother, has seen countless doctors and taken many types of medicine, vitamins and supplementsContinue Reading
THURSDAY, Nov. 18, 2021 (HealthDay News) — Moderna asked the U.S. Food and Drug Administration on Wednesday to allow emergency use of the company’s coronavirus vaccine booster for all adults aged 18 and older. Currently, the booster is approved for people 65 and older, along with adults in long-term careContinue Reading